Phase 1 Study of Chemotherapy Plus HLA-mismatched GPBMC Infusion Bridging to Allo-HSCT for R/R Leukemia

Clinical trial NCT07297173 · RECRUITING

Trial details

NCT number: NCT07297173
Sponsor: Beijing 302 Hospital
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed Leukemia Refractory Leukemia

Start date: 2025-12-01
Primary completion: 2028-12-01
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.